Ameritas Investment Partners’s ClearPoint Neuro CLPT Stock Holding History

Ameritas Investment Partners’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.2K	Hold	2,225	–	–	﹤0.01%	2590
2025 Q4	$30.4K	Hold	2,225	–	–	﹤0.01%	2433
2025 Q3	$48.5K	Sell	2,225 -435	-16%	-$5.12K	﹤0.01%	2145
2025 Q2	$31.8K	Buy	+2,660	New	+$33.5K	﹤0.01%	2457
2024 Q2	–	Sell	-1,893	Closed	-$12.9K	–	3146
2024 Q1	$12.9K	Hold	1,893	–	–	﹤0.01%	2746
2023 Q4	$12.9K	Hold	1,893	–	–	﹤0.01%	2761
2023 Q3	$9.48K	Hold	1,893	–	–	﹤0.01%	2852
2023 Q2	$13.7K	Buy	+1,893	New	+$16.1K	﹤0.01%	2767
2022 Q2	–	Sell	-1,475	Closed	-$15K	–	3095
2022 Q1	$15K	Hold	1,475	–	–	﹤0.01%	2661
2021 Q4	$17K	Hold	1,475	–	–	﹤0.01%	2704
2021 Q3	$26K	Hold	1,475	–	–	﹤0.01%	2553
2021 Q2	$28K	Buy	+1,475	New	+$28.5K	﹤0.01%	2543

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameritas Investment Partners's CLPT Position: Q1 2026 in Review

Ameritas Investment Partners held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 2,225 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Ameritas Investment Partners first reported a position in CLPT in Q2 2021 and has held it in 12 quarters since. The position peaked at $48.5K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Ameritas Investment Partners held 2,225 shares of ClearPoint Neuro worth $20.2K as of Q1 2026.
Ameritas Investment Partners left its ClearPoint Neuro share count unchanged in Q1 2026.
ClearPoint Neuro made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2590 holding.
Ameritas Investment Partners first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 12 quarters since.
Ameritas Investment Partners's ClearPoint Neuro position peaked at $48.5K in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.